Prognostic Value of Histologic Subtype and Treatment Modality for T1a Kidney Cancers.

Siev, Michael; Renson, Audrey; Tan, Hung-Jui; Rose, Tracy L; Kang, Stella K; Huang, William C; Bjurlin, Marc A

Siev, Michael; Renson, Audrey; Tan, Hung-Jui; Rose, Tracy L; Kang, Stella K; Huang, William C; Bjurlin, Marc A.

Afiliación

Siev M; Department of Urology, Division of Urologic Oncology, NYU Langone Health, New York, NY, USA.
Renson A; Department of Clinical Research, NYU Langone Hospital - Brooklyn, Brooklyn, NY, USA.
Tan HJ; Department of Urology, Lineberger Comprehensive Cancer Center, Multidisciplinary Genitourinary Oncology, University of North Carolina, Chapel Hill, NC, USA.
Rose TL; Department of Hematology/Oncology, Lineberger Comprehensive Cancer Center, Multidisciplinary Genitourinary Oncology, University of North Carolina, Chapel Hill, NC, USA.
Kang SK; Department of Radiology, NYU Langone Health, New York, NY, USA.
Huang WC; Department of Population Health, NYU Langone Health, New York, NY, USA.
Bjurlin MA; Department of Urology, Division of Urologic Oncology, NYU Langone Health, New York, NY, USA.

Kidney Cancer ; 4(1): 49-58, 2020.

Article en En | MEDLINE | ID: mdl-34084980

Palabras clave

Renal cell carcinoma; T1a; histologic subtype; overall survival; partial nephrectomy; percutaneous ablation; radical nephrectomy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Kidney Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google